AMAG
AMAG Pharmaceuticals, Inc.
AMAG
AMAG
Delisted
AMAG was delisted on the 13th of November, 2020.
187 hedge funds and large institutions have $774M invested in AMAG Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 54 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
187
Holders Change
+13
Holders Change %
+7.47%
% of All Funds
4.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
68
Reduced
54
Closed
20
Calls
$3.87M
Puts
$16.4M
Net Calls
-$12.5M
Net Calls Change
-$3.13M
Top Buyers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$17.5M |
| 2 |
PP
PDT Partners
New York
|
+$5.41M |
| 3 |
D.E. Shaw & Co
New York
|
+$4.4M |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$3.96M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.95M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$25.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$21.4M |
| 3 |
GAM
Gotham Asset Management
New York
|
-$6.8M |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.04M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.01M |
